OTCMKTS:PTEO Proteo (PTEO) Stock Price, News & Analysis $0.09 0.00 (0.00%) As of 09/27/2022 Add Compare Share Share Stock Analysis Stock Analysis About Proteo Stock (OTCMKTS:PTEO) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Proteo alerts:Sign Up Key Stats Today's Range$0.09▼$0.0950-Day Range$0.09▼$0.0952-Week Range$20.00▼$698.00VolumeN/AAverage Volume11 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewProteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded in 1992 and is based in Irvine, California.Read More… Receive PTEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Proteo and its competitors with MarketBeat's FREE daily newsletter. Email Address PTEO Stock News HeadlinesLTHO Legacy Technology Holdings, Inc.October 26, 2024 | seekingalpha.comITONF Ito En, Ltd. Class A Preferred SharesSeptember 28, 2024 | seekingalpha.comKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behind closed doors with some of America’s savviest investors. The obscure, little-known companies we believe could 5x, even 10x, under Trump’s second term…January 22, 2025 | Porter & Company (Ad)Homenaje a Proteo y el último desfile militar encabezado por AMLOSeptember 16, 2024 | msn.comKey Proteo seeks FDA approval for diagnostic newborn screening panelApril 1, 2024 | msn.comA un año de su muerte, ejército mexicano recuerda a Proteo, el perro rescatista que murió en TurquíaFebruary 13, 2024 | msn.comSedena conmemora el primer aniversario luctuoso de Proteo, el perro rescatistaFebruary 13, 2024 | msn.comA un año de su muerte, Sedena recuerda a Proteo, binomio canino que falleció en Turquía tras terremotoFebruary 12, 2024 | msn.comSee More Headlines PTEO Stock Analysis - Frequently Asked Questions How have PTEO shares performed this year? Proteo's stock was trading at $0.0899 on January 1st, 2025. Since then, PTEO stock has increased by 0.0% and is now trading at $0.0899. View the best growth stocks for 2025 here. How do I buy shares of Proteo? Shares of PTEO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Proteo own? Based on aggregate information from My MarketBeat watchlists, some other companies that Proteo investors own include ASAP (WTRH), Trigon Metals (TM), SoundThinking (SSTI), PagSeguro Digital (PAGS), Kaya (KAYS) and Energizer (ENR). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:PTEO CUSIPN/A CIK1063104 Webproteo.us Phone+1-949-2534616FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.Get This Free Report This page (OTCMKTS:PTEO) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersTexas embraces new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Proteo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Proteo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.